Literature DB >> 22138156

Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.

R J Newsom1, C Osterlund, C V Masini, H E Day, R L Spencer, S Campeau.   

Abstract

Altered regulation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with stress-induced changes in cognitive, emotional, and physical health. Recent evidence indicates that the endogenous cannabinoid (eCB) system may modulate HPA-axis function both directly and more centrally, via regulation of limbic brain systems that control HPA-axis activity. The current study examines the contribution of cannabinoid type 1 (CB1) receptor modulation throughout the neuraxis on control and stress-induced HPA-axis activity. Adult male Sprague-Dawley rats were given intraperitoneal injections of either CB1 receptor antagonist (AM251, 2 mg/kg) or vehicle 30 min prior to a session of loud white noise stress (95 dBA for 30 min) or placement in a familiar sound-proof chamber. Immediately following stress and control treatments, rats were killed, the brains and pituitary glands were excised for subsequent immediate early gene (c-fos mRNA) measurement, and trunk blood was collected for subsequent determination of corticosterone (CORT) and adrenocorticotropic (ACTH) hormone levels. AM251 treatment resulted in a potentiated plasma ACTH response to loud noise stress. AM251 treatment also increased stress-induced plasma CORT levels, but that increase may be due to an increase in basal plasma CORT levels, as was evident in control rats. AM251 treatment produced three distinctive c-fos mRNA response patterns across the various brain regions examined. In cortical (prelimbic, infralimbic, somatosensory, and auditory) and some subcortical structures (basolateral amygdala and paraventricular nucleus of the hypothalamus), AM251 treatment produced a substantial increase in c-fos mRNA that was comparable with the elevated c-fos mRNA levels present in those brain regions of both vehicle and AM251-treated stressed rats. In some other subcortical structures (bed nucleus of the stria terminalis and medial preoptic area) and the anterior pituitary, AM251 treatment produced a c-fos mRNA response pattern that was similar to the response pattern of ACTH hormone levels, that is, no effect on no noise control levels, but an augmentation of stress-induced levels. Conversely, in the medial geniculate and ventral posterior thalamus, AM251 treatment inhibited stress-induced c-fos mRNA induction. These data indicate that disruption of eCB signaling through CB1 receptors results in potentiated neural and endocrine responses to loud noise stress, but also substantial increases in activity in various brain regions and the adrenal gland. Copyright Â
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138156      PMCID: PMC3288505          DOI: 10.1016/j.neuroscience.2011.11.043

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  46 in total

Review 1.  Endocannabinoids and energy metabolism.

Authors:  U Pagotto; R Pasquali
Journal:  J Endocrinol Invest       Date:  2006       Impact factor: 4.256

2.  Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.

Authors:  David J Rademacher; Sarah E Meier; Leyu Shi; W-S Vanessa Ho; Abbas Jarrahian; Cecilia J Hillard
Journal:  Neuropharmacology       Date:  2007-06-29       Impact factor: 5.250

3.  Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus.

Authors:  Matthew N Hill; Erica J Carrier; W-S Vanessa Ho; Leyu Shi; Sachin Patel; Boris B Gorzalka; Cecilia J Hillard
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

4.  Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons.

Authors:  Shi Di; Renato Malcher-Lopes; Victor L Marcheselli; Nicolas G Bazan; Jeffrey G Tasker
Journal:  Endocrinology       Date:  2005-06-30       Impact factor: 4.736

5.  A detailed characterization of loud noise stress: Intensity analysis of hypothalamo-pituitary-adrenocortical axis and brain activation.

Authors:  Andrew Burow; Heidi E W Day; Serge Campeau
Journal:  Brain Res       Date:  2005-10-25       Impact factor: 3.252

6.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.

Authors:  Daniela Cota; Michel-Alexander Steiner; Giovanni Marsicano; Cristina Cervino; James P Herman; Yvonne Grübler; Johanna Stalla; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  Endocrinology       Date:  2006-12-28       Impact factor: 4.736

7.  Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.

Authors:  Sachin Patel; Craig T Roelke; David J Rademacher; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

8.  Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.

Authors:  Shi Di; Cherif Boudaba; Ion R Popescu; Feng-Ju Weng; Christina Harris; Victor L Marcheselli; Nicolas G Bazan; Jeffrey G Tasker
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

9.  Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice.

Authors:  Michel A Steiner; Giovanni Marsicano; Eric J Nestler; Florian Holsboer; Beat Lutz; Carsten T Wotjak
Journal:  Psychoneuroendocrinology       Date:  2007-10-31       Impact factor: 4.905

10.  BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice.

Authors:  Ester Aso; Andrés Ozaita; Elsa M Valdizán; Catherine Ledent; Angel Pazos; Rafael Maldonado; Olga Valverde
Journal:  J Neurochem       Date:  2007-11-28       Impact factor: 5.372

View more
  18 in total

1.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

Review 2.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

Review 3.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

Review 4.  Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis.

Authors:  M N Hill; J G Tasker
Journal:  Neuroscience       Date:  2011-12-24       Impact factor: 3.590

5.  Endocannabinoid Signaling in the Stress Response of Male and Female Songbirds.

Authors:  Molly J Dickens; Haley A Vecchiarelli; Matthew N Hill; George E Bentley
Journal:  Endocrinology       Date:  2015-10-02       Impact factor: 4.736

6.  Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.

Authors:  J Megan Gray; Haley A Vecchiarelli; Maria Morena; Tiffany T Y Lee; Daniel J Hermanson; Alexander B Kim; Ryan J McLaughlin; Kowther I Hassan; Claudia Kühne; Carsten T Wotjak; Jan M Deussing; Sachin Patel; Matthew N Hill
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

Review 7.  Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Cecilia J Hillard; Margaret Beatka; Jenna Sarvaideo
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 8.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

Review 9.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

10.  Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats.

Authors:  Lucas Gomes-de-Souza; Leandro A Oliveira; Ricardo Benini; Patrícia Rodella; Willian Costa-Ferreira; Carlos C Crestani
Journal:  Br J Pharmacol       Date:  2016-08-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.